Ads
related to: gastrointestinal carcinoid tumor treatment- Schedule an Appointment
Schedule an Appointment Today.
Call Our Cancer Answer Line.
- Sarcoma Treatment Options
Talk to a Sarcoma Expert
Understand Your Treatment Options.
- Virtual Second Opinions
Get Peace of Mind from Home.
Review Your Diagnosis & Treatment.
- Sarcoma Second Opinions
In Need of a Second Opinion?
Our Cancer Answer Line Can Help.
- Schedule an Appointment
Search results
Results from the WOW.Com Content Network
A gastrointestinal carcinoid tumor is a rare, slow-growing form of cancer that affects certain cells in the lining of the stomach and intestines. The cells it affects make hormones that regulate the production of digestive juices and muscles that move food through the stomach and intestines.
Carcinoid tumors are the most common malignant tumor of the appendix, but they are most commonly associated with the small intestine, and they can also be found in the rectum and stomach. They are known to grow in the liver, but this finding is usually a manifestation of metastatic disease from a primary carcinoid occurring elsewhere in the body.
Small intestinal neuroendocrine tumors were first distinguished from other tumors in 1907. [105] [48] They were named carcinoid tumors because their slow growth was considered to be "cancer-like" rather than truly cancerous. [48] However, in 1938 it was recognized that some of these small bowel tumors could be malignant.
It is relatively rare compared to other gastrointestinal malignancies such as gastric cancer (stomach cancer) and colorectal cancer. [ 1 ] [ 2 ] Small intestine cancer can be subdivided into duodenal cancer (the first part of the small intestine) and cancer of the jejunum and ileum (the latter two parts of the small intestine).
A small intestine neuroendocrine tumor is a carcinoid in the distal small intestine or the proximal large intestine. It is a relatively rare cancer and is diagnosed in approximately 1/100000 people every year. In recent decades the incidence has increased. [1]
It is also effective in suppression of the carcinoid syndrome, caused by advanced or extra-gastrointestinal carcinoid tumors. Octreotide may also be used for treatment of severe diarrhea caused by 5-fluorouracil chemotherapy or radiation therapy .
Ads
related to: gastrointestinal carcinoid tumor treatment